AU2002220025A1 - Rotavirus enterotoxin NSP4 and methods of using same - Google Patents
Rotavirus enterotoxin NSP4 and methods of using sameInfo
- Publication number
- AU2002220025A1 AU2002220025A1 AU2002220025A AU2002502A AU2002220025A1 AU 2002220025 A1 AU2002220025 A1 AU 2002220025A1 AU 2002220025 A AU2002220025 A AU 2002220025A AU 2002502 A AU2002502 A AU 2002502A AU 2002220025 A1 AU2002220025 A1 AU 2002220025A1
- Authority
- AU
- Australia
- Prior art keywords
- nsp4
- peptide
- nucleic acid
- protein
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/705,621 US6673355B1 (en) | 1995-06-14 | 2000-11-03 | Rotavirus enterotoxin NSP4 and methods of using same |
US09/705,621 | 2000-11-03 | ||
PCT/US2001/045255 WO2002036172A2 (fr) | 2000-11-03 | 2001-11-02 | Enterotoxine nsp4 de rotavirus et ses methodes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002220025A1 true AU2002220025A1 (en) | 2002-05-15 |
Family
ID=24834264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002220025A Abandoned AU2002220025A1 (en) | 2000-11-03 | 2001-11-02 | Rotavirus enterotoxin NSP4 and methods of using same |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1349571A4 (fr) |
AU (1) | AU2002220025A1 (fr) |
CA (1) | CA2427809A1 (fr) |
WO (1) | WO2002036172A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1576877A1 (fr) * | 2004-03-04 | 2005-09-21 | Bioprotein Technologies | Production de protéines recombinantes de rotavirus dans le lait d'animaux transgéniques non-humains |
WO2007081447A2 (fr) | 2005-11-22 | 2007-07-19 | Novartis Vaccines And Diagnostics, Inc. | Antigènes de norovirus et de sapovirus |
HUE033858T2 (en) * | 2012-02-14 | 2018-01-29 | Merial Inc | Rotavirus unit vaccines and method for their preparation and use |
CN104661675B (zh) * | 2012-05-16 | 2019-04-30 | 阿德莱德研究创新私人有限公司 | 细胞疫苗和诱导受试者免疫反应的方法 |
EA201791683A1 (ru) * | 2015-01-23 | 2017-12-29 | Медикаго Инк. | Получение ротавирусоподобных частиц в растениях |
CN108504718A (zh) * | 2018-03-27 | 2018-09-07 | 东莞市第三人民医院 | 一种CaSR在RV、NSP4感染后的表达水平分析方法 |
CN117866858B (zh) * | 2023-11-30 | 2024-06-21 | 吉林农业大学 | 一种表达猪轮状病毒抗原的重组植物乳杆菌及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5186933A (en) * | 1986-12-30 | 1993-02-16 | Baylor College Of Medicine | Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
US5298244A (en) * | 1990-10-25 | 1994-03-29 | University Of Saskatchewan | Assembled viral particles and their use in a vaccine to rotaviral disease |
AU6387196A (en) * | 1995-06-14 | 1997-01-15 | Baylor College Of Medicine | Rotavirus enterotoxin nsp4 and methods of using same |
AU1202201A (en) * | 1999-10-14 | 2001-04-23 | Baylor College Of Medicine | A novel adjuvant |
FR2806087B1 (fr) * | 2000-03-07 | 2002-10-18 | Agronomique Inst Nat Rech | Particules pseudovirales de rotavirus et leur utilisation pour vectoriser des proteines ou des acides nucleiques |
-
2001
- 2001-11-02 AU AU2002220025A patent/AU2002220025A1/en not_active Abandoned
- 2001-11-02 CA CA002427809A patent/CA2427809A1/fr not_active Abandoned
- 2001-11-02 WO PCT/US2001/045255 patent/WO2002036172A2/fr not_active Application Discontinuation
- 2001-11-02 EP EP01992588A patent/EP1349571A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002036172A3 (fr) | 2002-09-19 |
CA2427809A1 (fr) | 2002-05-10 |
EP1349571A4 (fr) | 2005-02-16 |
EP1349571A2 (fr) | 2003-10-08 |
WO2002036172A2 (fr) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dalsgaard et al. | Plant–derived vaccine protects target animals against a viral disease | |
US5690938A (en) | Oral immunization with multiple particulate antigen delivery system | |
Horie et al. | Diarrhea induction by rotavirus NSP4 in the homologous mouse model system | |
US20220313812A1 (en) | Senecavirus a immunogenic compositions and methods thereof | |
KR20190110605A (ko) | 돼지 코로나바이러스 백신 | |
US6673355B1 (en) | Rotavirus enterotoxin NSP4 and methods of using same | |
NO341881B1 (no) | Polypeptid, protein, metode for fremstilling av salmonid alphavirus nøytraliserende antistoffer, nukleinsyre, bærer, vaksine og diagnostisk sett | |
US8685411B2 (en) | Rotavirus antigens | |
JP2023544396A (ja) | ロタウイルスに対するワクチン接種のために有用な融合タンパク質 | |
JPH06504190A (ja) | アセンブルしたウイルス粒子およびロタウイルス疾患ワクチンにおけるその使用 | |
US6210682B1 (en) | Rotavirus enterotoxin NSP4 and methods of using same | |
AU2002220025A1 (en) | Rotavirus enterotoxin NSP4 and methods of using same | |
CN108431214B (zh) | 人轮状病毒g9p[6]毒株和作为疫苗的用途 | |
US20030175303A1 (en) | Production method of recombinant rotavirus structural proteins and vaccine composition | |
Viaplana et al. | Antigenicity of VP60 structural proteinof rabbit haemorrhagic disease virus | |
WO2004009115A1 (fr) | Sous-unite vp6 de rotavirus | |
AU768605B2 (en) | Rotavirus enterotoxin NSP4 and methods of using same | |
KR101671528B1 (ko) | 돼지 유행성 설사병 바이러스의 에피토프와 점막면역보조제를 발현하는 형질전환체 및 이를 포함하는 백신 조성물 | |
US20240050555A1 (en) | Immunogenic composition useful for vaccination against rotavirus | |
JP2023544403A (ja) | サーコウイルス科カプシドタンパク質を含む融合タンパク質、及びそれから構成されるキメラウイルス様粒子 | |
WO1989006971A1 (fr) | Segments de genes de rotavirus conserves et utilisation de tels segments dans des techniques d'immunisation et de neutralisation | |
CN117959420A (zh) | 一种猪流行性腹泻病毒二价亚单位疫苗及制备方法 | |
Ren | Epitope mapping of the non-structural protein 2 (NSP2) of rotavirus | |
Both et al. | Analysis of Rotavirus Proteins by Gene Cloning, Mutagenesis, and Expression | |
Kim | Detection of group C Rotaviruses in Feeder Pigs, production of group a/c rotavirus-like particles (VLPS) and use of group A VLP Vaccines in cattle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |